EPG Wealth Management LLC Makes New $766,000 Investment in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

EPG Wealth Management LLC purchased a new stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund purchased 9,801 shares of the company's stock, valued at approximately $766,000.

Several other large investors have also made changes to their positions in the company. CoreFirst Bank & Trust bought a new stake in GE HealthCare Technologies during the fourth quarter worth approximately $25,000. Runnymede Capital Advisors Inc. bought a new stake in GE HealthCare Technologies during the fourth quarter worth approximately $28,000. LGT Financial Advisors LLC boosted its position in GE HealthCare Technologies by 46.2% during the fourth quarter. LGT Financial Advisors LLC now owns 389 shares of the company's stock worth $30,000 after purchasing an additional 123 shares during the period. Accredited Wealth Management LLC bought a new stake in GE HealthCare Technologies during the fourth quarter worth approximately $30,000. Finally, Bank of Jackson Hole Trust bought a new stake in GE HealthCare Technologies during the fourth quarter worth approximately $32,000. Institutional investors own 82.06% of the company's stock.

Analyst Ratings Changes

GEHC has been the subject of a number of recent analyst reports. Citigroup decreased their target price on GE HealthCare Technologies from $105.00 to $86.00 and set a "buy" rating for the company in a research report on Wednesday, April 30th. BTIG Research set a $95.00 price objective on GE HealthCare Technologies and gave the company a "buy" rating in a research report on Monday, April 14th. Piper Sandler reduced their price objective on GE HealthCare Technologies from $104.00 to $88.00 and set an "overweight" rating for the company in a research report on Wednesday, April 23rd. Morgan Stanley reduced their price objective on GE HealthCare Technologies from $86.00 to $78.00 and set an "equal weight" rating for the company in a research report on Tuesday, May 6th. Finally, Wells Fargo & Company reduced their price objective on GE HealthCare Technologies from $103.00 to $89.00 and set an "overweight" rating for the company in a research report on Thursday, May 1st. Three investment analysts have rated the stock with a hold rating, eight have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $88.27.

GE HealthCare Technologies Price Performance

GE HealthCare Technologies stock traded up $4.46 during mid-day trading on Monday, hitting $74.33. 4,140,610 shares of the company were exchanged, compared to its average volume of 3,365,945. The company has a quick ratio of 0.83, a current ratio of 1.04 and a debt-to-equity ratio of 0.88. The business has a fifty day moving average of $72.49 and a 200 day moving average of $80.58. GE HealthCare Technologies Inc. has a 1-year low of $57.65 and a 1-year high of $94.80. The company has a market capitalization of $34.04 billion, a PE ratio of 17.10, a price-to-earnings-growth ratio of 3.19 and a beta of 1.21.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last announced its earnings results on Wednesday, April 30th. The company reported $1.01 earnings per share for the quarter, beating analysts' consensus estimates of $0.91 by $0.10. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. The company had revenue of $4.78 billion during the quarter, compared to analyst estimates of $4.66 billion. During the same period last year, the company posted $0.90 earnings per share. The firm's quarterly revenue was up 2.7% compared to the same quarter last year. As a group, sell-side analysts expect that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

GE HealthCare Technologies Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, May 15th. Investors of record on Friday, April 25th will be issued a $0.035 dividend. This represents a $0.14 annualized dividend and a yield of 0.19%. The ex-dividend date of this dividend is Friday, April 25th. GE HealthCare Technologies's dividend payout ratio is 2.95%.

GE HealthCare Technologies declared that its board has initiated a stock repurchase plan on Wednesday, April 30th that permits the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization permits the company to reacquire up to 3.1% of its stock through open market purchases. Stock repurchase plans are typically an indication that the company's leadership believes its shares are undervalued.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.